(4-NH2)-Exatecan |
Catalog No.GC65358 |
Le (4-NH2)-Exatecan, un dérivé inhibiteur de la topoisomérase extrait du brevet US20200306243A1, composé A. Le (4-NH2)-Exatecan peut être utilisé dans la synthèse de conjugués anticorps-médicament (ADC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2495742-21-5
Sample solution is provided at 25 µL, 10mM.
(4-NH2)-Exatecan, a topoisomerase inhibitor derivative extracted from patent US20200306243A1, compound A. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs)[1].
[1]. Howard PW, et, al. Compounds and conjugates thereof. US20200306243A1.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *